Literature DB >> 33062181

Brain Permeable Tafamidis Amide Analogs for Stabilizing TTR and Reducing APP Cleavage.

Anjana Sinha1, Jerry C Chang1,2, Peng Xu1, Katherina Gindinova1, Younhee Cho3, Weilin Sun1, Xianzhong Wu2, Yue Ming Li2, Paul Greengard1, Jeffery W Kelly3, Subhash C Sinha1.   

Abstract

Tafamidis, 1, a potent transthyretin kinetic stabilizer, weakly inhibits the γ-secretase enzyme in vitro. We have synthesized four amide derivatives of 1. These compounds reduce production of the Aβ peptide in N2a695 cells but do not inhibit the γ-secretase enzyme in cell-free assays. By performing fluorescence correlation spectroscopy, we have shown that TTR inhibits Aβ oligomerization and that addition of tafamidis or its amide derivative does not affect TTR's ability to inhibit Aβ oligomerization. The piperazine amide derivative of tafamidis (1a) efficiently penetrates and accumulates in mouse brain and undergoes proteolysis under physiological conditions in mice to produce tafamidis.

Entities:  

Year:  2020        PMID: 33062181      PMCID: PMC7549266          DOI: 10.1021/acsmedchemlett.9b00688

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  38 in total

1.  Small molecule quantification by liquid chromatography-mass spectrometry for metabolites of drugs and drug candidates.

Authors:  Upendra P Dahal; Jeffrey P Jones; John A Davis; Dan A Rock
Journal:  Drug Metab Dispos       Date:  2011-09-21       Impact factor: 3.922

Review 2.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

3.  Transthyretin sequesters amyloid beta protein and prevents amyloid formation.

Authors:  A L Schwarzman; L Gregori; M P Vitek; S Lyubski; W J Strittmatter; J J Enghilde; R Bhasin; J Silverman; K H Weisgraber; P K Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

4.  Development of Gleevec Analogues for Reducing Production of β-Amyloid Peptides through Shifting β-Cleavage of Amyloid Precursor Proteins.

Authors:  Weilin Sun; William J Netzer; Anjana Sinha; Katherina Gindinova; Emily Chang; Subhash C Sinha
Journal:  J Med Chem       Date:  2019-03-15       Impact factor: 7.446

Review 5.  The secretases: enzymes with therapeutic potential in Alzheimer disease.

Authors:  Bart De Strooper; Robert Vassar; Todd Golde
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

6.  Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.

Authors:  W Colon; J W Kelly
Journal:  Biochemistry       Date:  1992-09-15       Impact factor: 3.162

7.  Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus.

Authors:  G Schreiber; A R Aldred; A Jaworowski; C Nilsson; M G Achen; M B Segal
Journal:  Am J Physiol       Date:  1990-02

8.  Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.

Authors:  Carlos A Ribeiro; Sandra Marisa Oliveira; Luis F Guido; Ana Magalhães; Gregorio Valencia; Gemma Arsequell; Maria João Saraiva; Isabel Cardoso
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 9.  Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

Authors:  Xinyi Li; Joel N Buxbaum
Journal:  Mol Neurodegener       Date:  2011-11-23       Impact factor: 14.195

10.  Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1?

Authors:  Mobina Alemi; Cristiana Gaiteiro; Carlos Alexandre Ribeiro; Luís Miguel Santos; João Rodrigues Gomes; Sandra Marisa Oliveira; Pierre-Olivier Couraud; Babette Weksler; Ignacio Romero; Maria João Saraiva; Isabel Cardoso
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more
  1 in total

1.  Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis.

Authors:  Bokyung Kim; Young Ho Ko; Massimiliano Runfola; Simona Rapposelli; Gabriella Ortore; Grazia Chiellini; Jin Hae Kim
Journal:  Int J Mol Sci       Date:  2021-03-28       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.